SNDX
SNDX
NASDAQ · Biotechnology

Syndax Pharmaceuticals Inc

$9.55
+0.18 (+1.92%)
As of Nov 7, 1:43 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +156.4% upside
Low Target $15.15
Average Target $24.49
High Target $32.88
Current Price $9.55
Current
$9.55
Target
$24.49
$15.15 $24.49 avg $32.88
Scenario Analysis
Bear Case
$15.15
58.6%
Low target
Base Case
$24.49
+156.4%
Avg target
Bull Case
$32.88
+244.3%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$25.59
-62.7% from high
52-Week Low
$9.29
+2.8% from low
50-Day SMA
$16.33
-41.5% vs SMA
200-Day SMA
$20.00
-52.3% vs SMA
RSI (14)
31.6
Neutral
Target vs 52W High
$24.49
-4.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%